PTEN and prostate carcinoma: In a mouse model of prostate cancer, PTEN loss resulted in a significant increased expression of sixteen miRNAs including miR-155 and miR-132, and a decreased expression of five miRNAs expression (among others: miR-133a and miR-181) [28].